The Dedham Group, “TDG,” is a specialized boutique management and strategy consulting company offering advisory services to the Life Sciences industry with a strong focus in the Oncology & Specialty Therapeutics space. TDG’s unique expertise in specialty healthcare economics, emerging access influencers, molecular diagnostics and commercial analytics provide our clients with a holistic approach in solving their greatest clinical and business issues facing their brands.
We’re extremely selective in working with specific types of clients generally those who are interested in driving real change and innovation within their organizations and the industry. Our goal and internal company philosophy is that we invest heavily in every client relationship to ensure that our clients are successful in both the short and long-term. Many times beyond a project – we provide strategic and management support from proprietary research and analyses to management of tactical execution.
Over the years, we’ve rapidly established ourselves as the preferred go-to strategic partner in many of the large premier biopharmaceutical companies in the US. Our core philosophy centers on that at every client interaction, we strive to advance their thinking by continuously delivering strategic insight from the marketplace. We believe that our strong commitment to insight and continued development of highly specialized therapeutic area expertise sets us apart from our competitors. We’re not a generalist management consulting company and we’re also not a market research firm that shadows as ‘consulting’. Our clients recognize this difference and as a result, in many of these companies, we work with C-suite clients and across the portfolio and not just a few brands.